De novo in silico screening of natural products for antidiabetic drug discovery: ADMET profiling, molecular docking, and molecular dynamics simulations
Loading...
Date
2025-02
Journal Title
Journal ISSN
Volume Title
Publisher
In Silico Pharmacology
Abstract
Epigenetic dysfunction which has implicated disease conditions such as diabetes highlights the urgency for the discovery
of novel therapeutic alternatives. The rising global incidences of diabetes and the limitations of existing treatments further
exacerbate the quest for novel antidiabetic agents’ discovery. This study leverages computational approaches to screen
selected bioactive natural product phytoconstituents for their potential anti-diabetic properties. Utilizing pharmaceutical